Orion Capital Management LLC lifted its position in Edap Tms S.A. (NASDAQ:EDAP – Free Report) by 10.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 69,800 shares of the medical equipment provider’s stock after buying an additional 6,600 shares during the period. Orion Capital Management LLC’s holdings in Edap Tms were worth $178,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of EDAP. Commonwealth Equity Services LLC grew its position in Edap Tms by 5.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after purchasing an additional 4,000 shares during the last quarter. Redhawk Wealth Advisors Inc. purchased a new stake in Edap Tms during the 3rd quarter worth approximately $36,000. BNP Paribas Financial Markets grew its position in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares during the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new stake in Edap Tms during the 3rd quarter worth approximately $395,000. Hedge funds and other institutional investors own 62.74% of the company’s stock.
Analyst Upgrades and Downgrades
EDAP has been the subject of several research reports. HC Wainwright restated a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a research note on Thursday, August 29th. StockNews.com upgraded shares of Edap Tms from a “sell” rating to a “hold” rating in a research note on Thursday, December 5th.
Edap Tms Stock Performance
Shares of NASDAQ EDAP opened at $2.27 on Tuesday. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. The company has a 50 day simple moving average of $2.59 and a two-hundred day simple moving average of $3.82. Edap Tms S.A. has a 12 month low of $2.14 and a 12 month high of $8.50. The stock has a market cap of $84.22 million, a price-to-earnings ratio of -3.49 and a beta of 0.33.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Featured Stories
- Five stocks we like better than Edap Tms
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Amplitude an AI Sleeper Stock in the Making for 2025?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Pure Storage Rides the AI Boom Even Higher in 2025
- What is an Earnings Surprise?
- GXO Logistics: Time to Buy the Dip for the Rip in 2025
Want to see what other hedge funds are holding EDAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Edap Tms S.A. (NASDAQ:EDAP – Free Report).
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.